💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

US STOCKS-Wall St ticks up as weak data points to Fed's move

Published 09/28/2010, 12:33 PM
Updated 09/28/2010, 12:36 PM

* Consumer confidence worse than expected, home prices dip

* Apple slides at open, then cuts losses

* Walgreen jumps after earnings

* Dow up 0.4 pct, S&P up 0.3 pct, Nasdaq up 0.1 pct (Updates to midday, changes byline)

By Rodrigo Campos

NEW YORK, Sept 28 (Reuters) - U.S. stocks edged higher on Tuesday after weak consumer confidence figures, with investors saying the data bolsters expectations the Fed will pump more money into the economy, which would support equities.

The S&P 500 has risen 9 percent so far in September, making it one of the best months for the index in 20 years.

"Currently the bullish case (for stocks) is a 'win-win,'" said Joseph Battipaglia, market strategist at Stifel Nicolaus in Yardley, Pennsylvania.

"If the economy is good, that's good for stocks. If the economy is bad, it's good for stocks because the Fed is going to quantitatively ease."

Although he said the bullish case is "common knowledge," Battipaglia said he did not subscribe to it.

U.S. Treasury debt prices also rose as the weaker-than expected data added to expectations that the Federal Reserve will give the economy more support.

But the rally in bonds could be a bubble, Byron Wien, the vice chairman of Blackstone Advisory Partners, told Reuters Insider. He sees stocks moving higher, with little chance of another recession.

The Dow Jones industrial average gained 38.49 points, or 0.36 percent, to 10,850.53. The Standard & Poor's 500 Index rose 3.21 points, or 0.28 percent, to 1,145.36. The Nasdaq Composite Index edged up 3.17 points, or 0.13 percent, to 2,372.95.

Walgreen Co, the biggest U.S. drugstore chain, reported higher-than-expected quarterly earnings, helped by strong prescription drug sales. Its shares jumped 11.2 percent to $33.76.

Continuing the spurt of recent M&A activity, Endo Pharmaceuticals Holdings Inc will buy private generics maker Qualitest Pharmaceuticals for about $1.2 billion, marking its second deal in as many months. The stock advanced 8.7 percent to $33.26.

September data showed U.S. consumer confidence fell to its lowest level since February, underscoring lingering worries about the strength of the economic recovery, while home prices dipped in July.

Shares of Apple Inc dropped as much as 5.6 percent in early trading as rumors swirled that the company's No. 2 executive would join Hewlett-Packard.

Representatives from Apple and Hewlett-Packard declined to comment, and analysts quickly dismissed the rumor.

Apple shares slid 2.1 percent to $285.13 and HP rose 0.8 percent to $41.58. (Reporting by Rodrigo Campos; Editing by Jan Paschal)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.